Determination of platinum surface contamination in veterinary and human oncology centres using inductively coupled plasma mass spectrometry. (27th August 2013)

• Record Type: Journal Article
• Authors: Janssens, T.; Brouwers, E. E. M.; de Vos, J. P.; de Vries, N.; Schellens, J. H. M.; Beijnen, J. H.
• Is Part Of: Veterinary and comparative oncology. Volume 13:Number 3(2015:Sep.)
• Page Start: 305
• Page End: 313
• Publication Date: 2013-08-27
• Subjects: Veterinary oncology -- Periodicals; Neoplasms -- veterinary -- Periodicals; 636.0896994005
• DOI: 10.1111/vco.12049
• Languages: English
• ISSNs: 1476-5810

Abstract

<abstract abstract-type="main" id="vco12049-abs-0001"> <title>Abstract</title> <p id="vco12049-para-0001">The objective of this study was to determine the surface contamination with platinum‐containing antineoplastic drugs in veterinary and human oncology centres. Inductively coupled plasma mass spectrometry was used to measure platinum levels in surface samples. In veterinary and human oncology centres, 46.3 and 68.9% of the sampled surfaces demonstrated platinum contamination, respectively. Highest platinum levels were found in the preparation rooms (44.6 pg cm⁻²) in veterinary centres, while maximal levels in human centres were found in oncology patient‐only toilets (725 pg cm⁻²). Transference of platinum by workers outside areas where antineoplastic drugs were handled was observed in veterinary and human oncology centres. In conclusion, only low levels of platinum contamination attributable to carboplatin were found in the sampled veterinary oncology centres. However, dispersion of platinum outside areas where antineoplastic drugs were handled was detected in veterinary and human oncology centres. Consequently, not only personnel, but also others may be exposed to platinum.</p> </abstract>